A phase I study of the combination of gemcitabine (G), vinorelbine (V) and cisplatin (P) in patients (pts) with solid tumors.

被引：0
|
作者：
Schrijvers, D [1 ]
Dyck, J [1 ]
Van den Brande, J [1 ]
Wilmes, P [1 ]
Korst, A [1 ]
Lardon, F [1 ]
Vermorken, J [1 ]
机构：
[1] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
642P
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [41] Phase I study of ABT-888 in combination with carboplatin and gemcitabine in subjects with advanced solid tumors.
    Bell-McGuinn, Katherine M.
    Gray, Heidi J.
    Fleming, Gini F.
    Cristea, Mihaela C.
    Medina, Diane M.
    Xiong, Hao
    Dudley, Matthew W.
    Dunbar, Martin
    Giranda, Vincent L.
    Luo, Yan
    McKee, Mark D.
    Martin, Lainie P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] A phase I study of ARQ 197 in combination with temsirolimus in patients (Pts) with advanced stolid tumors.
    Braden, Amy M.
    Wisinski, Kari Braun
    Eickhoff, Jane C.
    Schelman, William R.
    Bailey, Howard Harry
    Mulkerin, Daniel
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] A phase I/I b study of GSK1120212 (trametinib) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
    Kurata, Takayasu
    Furuse, Junji
    Okamoto, Isamu
    Kasuga, Akiyoshi
    Fujisaka, Yasuhito
    Kitamura, Hiroshi
    Shimizu, Toshio
    Takasu, Atsuko
    Okamoto, Wataru
    Naruge, Daisuke
    Nagashima, Fumio
    Katsura, Koichi
    Mukaiyama, Akihira
    Matsushita, Hideki
    Nakagawa, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] A PHASE I COMBINATION STUDY OF AZD2281 AND CISPLATIN PLUS GEMCITABINE IN ADULTS WITH SOLID TUMORS
    Rajan, A.
    Gutierrez, M.
    Kummar, S.
    Yancey, M.
    Ji, J.
    Zhang, Y.
    Simmons, D.
    Parchment, R.
    Tomaszewski, J.
    Doroshow, J. H.
    Giaccone, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 42 - 43
  • [45] Biweekly vinorelbine and gemcitabine:: a phase I dose-finding study in patients with advanced solid tumors
    Castellano, D
    Hitt, R
    Ciruelos, E
    Cortés-Funes, H
    Colomer, R
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 783 - 787
  • [46] Results of a phase Ib study of ARQ 092 in combination with carboplatin (C) plus paclitaxel (P), or with P in patients (pts) with solid tumors.
    Lakhani, Nehal
    Tolcher, Anthony W.
    Rasco, Drew W.
    Patnaik, Amita
    O'Rourke, Timothy J.
    Schwartz, Brian E.
    Abbadessa, Giovanni
    Kazakin, Julia
    Savage, Ronald
    Wang, Yunxia
    Chai, Feng
    Papadopoulos, Kyriakos P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Comprehensive preclinically-guided phase I-II study supports the synergy of gemcitabine (GEM) in combination with oxaliplatin (OX) in patients (pts) with advanced solid tumors.
    Faivre, S
    Raymond, E
    Lokiec, F
    Monnerat, C
    Novello, S
    Ady-Vago, N
    Pautier, P
    Lhommé, C
    Kayitalire, L
    Armand, JP
    Le Chevalier, T
    CLINICAL CANCER RESEARCH, 2000, 6 : 4536S - 4536S
  • [48] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [49] Gemcitabine (G) and vinorelbine (V) in pretreated or elderly transitional cell carcinoma (TCC) patients (PTS): A phase II study
    Ferrau, F
    Bordonaro, R
    Aiello, R
    Cordio, S
    Failla, M
    Giuffrida, D
    Lavenia, G
    Pappalardo, A
    Priolo, D
    Failla, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S352 - S352
  • [50] Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
    Galsky, Matthew D.
    Posner, Marshall
    Holcombe, Randall F.
    Lee, Karen M.
    Misiukiewicz, Krzysztof
    Tsao, Che-Kai
    Godbold, James
    Soto, Rothschild
    Gimpel-Tetra, Kiev
    Lowe, Nancy
    Oh, William K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 465 - 471
12345